PureTech Health
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of PureTech Health generated cash of -$105,917,000, which is more than the previous year. Cash used in financing activities reached the amount of $78,141,000 last year. Net change in cash is therefore $41,215,000.
Cash Flow
| 2014 | -10.54M | 747K | 64.72M |
|---|---|---|---|
| 2015 | -28.61M | -184.24M | 285.93M |
| 2016 | -58.03M | -43.23M | 29.48M |
| 2017 | -88.68M | 83.68M | 14.69M |
| 2018 | -72.79M | -39.64M | 156.88M |
| 2019 | -98.15M | 63.65M | 49.91M |
| 2020 | -131.82M | 364.47M | 38.86M |
| 2021 | -158.27M | 197.37M | 22.72M |
| 2022 | -178.79M | -107.22M | -29.82M |
| 2023 | -105.91M | 68.99M | 78.14M |
PRTC.L Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 149.86M | 465.70M | 403.88M | 132.36M | 117.05M | 72.64M | 62.95M | 134.75M | 61.96M | 7.17M |
Operating activities | ||||||||||
Net income | -66.62M | -37.06M | -62.70M | 4.56M | 366.06M | -70.65M | -70.69M | -81.60M | -58.24M | -75.94M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 4.93M | 8.89M | 7.28M | 6.64M | 6.66M | 2.77M | 2.09M | 1.57M | 740K | 455K |
Stock-based compensation expense | 4.41M | 14.69M | 13.95M | 10.71M | 14.46M | 0 | 11.84M | 10.15M | 11.09M | 2.81M |
| Deferred income tax benefit | 4.41M | 14.69M | 13.95M | 10.71M | 14.46M | 0 | 11.84M | 10.15M | 11.09M | 2.81M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 9.75M | -7.73M | -617K | -529K | 747K | 467K | -1.67M | 581K | 1.11M | 794K |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | -105.91M | -178.79M | -158.27M | -131.82M | -98.15M | -72.79M | -88.68M | -58.03M | -28.61M | -10.54M |
Investing activities | ||||||||||
Purchases Of Investments | -195.71M | -268.73M | -500K | -1.15M | -91.24M | -169.95M | -147.20M | -312.82M | -385.38M | -2.21M |
Investments In Property Plant And Equipment | -70K | -2.17M | -5.66M | -5.42M | -12.53M | -4.49M | -2.17M | -3.67M | -4.61M | -420K |
Acquisitions Net | -13.78M | -20.44M | 321K | -10M | -16.03M | -13.39M | -16.34M | 0 | 1.15M | 53K |
Cash generated by investing activities | 68.99M | -107.22M | 197.37M | 364.47M | 63.65M | -39.64M | 83.68M | -43.23M | -184.24M | 747K |
Financing activities | ||||||||||
Common Stock Issued | 1.15M | 332K | -12.91M | -11.76M | 0 | 152.03M | 12.4M | 27.26M | 235.65M | 55.84M |
Payments for dividends | 0 | 0 | 0 | 0 | -112K | 0 | -91K | 0 | 0 | -96K |
Repurchases of common stock | -19.65M | -26.49M | -2.58M | 0 | 0 | -35K | -66K | 0 | 0 | 9.07M |
Repayments of term debt | 0 | -4.02M | -3.37M | -2.90M | 1.42M | -185K | 2.45M | 0 | 1.47M | -20K |
Cash used in financing activities | 78.14M | -29.82M | 22.72M | 38.86M | 49.91M | 156.88M | 14.69M | 29.48M | 285.93M | 64.72M |
Net Change In Cash | 41.21M | -315.84M | 61.82M | 271.52M | 15.30M | 44.40M | 9.69M | -71.79M | 72.79M | 54.78M |
Cash at end of period | 191.08M | 149.86M | 465.70M | 403.88M | 132.36M | 117.05M | 72.64M | 62.95M | 134.75M | 61.96M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |